PURPOSE: The study aimed to describe the dispensing of benzodiazepines and benzodiazepine-related drugs (z-hypnotics) to pregnant women and to study the characteristics of these women and the extent of co-medication. METHODS: A population-based cohort study was conducted based on the linkage of nationwide registries: the Medical Birth Registry of Norway and the Norwegian Prescription Database. The data covers dispensed drugs to women 3 months prior to, during and after pregnancy. The study population consisted of 345,703 singleton pregnancies during a period starting 1 April 2004 or later and ending before 1 January 2011. RESULTS: In 5,135 (1.5 %) of the pregnancies, the women were dispensed a benzodiazepine or z-hypnotic at least once. Of these, 68.5 % filled just one prescription for the duration of the pregnancy. Prevalence was lower in pregnancy than before and after pregnancy. The median total amount of benzodiazepines and/or z-hypnotics dispensed during pregnancy was 15 defined daily doses (DDDs), while the 25 % receiving the largest amounts got 40 DDDs or more. Five hundred eleven women, the 10 % that were prescribed the largest amounts during pregnancy, received a median amount of 220 DDDs. Women receiving these drugs were older, more often smokers, without a partner and suffering from chronic disease. Of the medicated pregnant women, 19.6 % and 19.3 % were also prescribed an opioid and antidepressant, respectively. CONCLUSIONS: The use of benzodiazepines and z-hypnotic drugs during pregnancy was not very prevalent in Norway. However, our findings imply that there is a substantial number of pregnancies where these drugs are dispensed often and/or in large quantities and where co-medication occurred.
PURPOSE: The study aimed to describe the dispensing of benzodiazepines and benzodiazepine-related drugs (z-hypnotics) to pregnant women and to study the characteristics of these women and the extent of co-medication. METHODS: A population-based cohort study was conducted based on the linkage of nationwide registries: the Medical Birth Registry of Norway and the Norwegian Prescription Database. The data covers dispensed drugs to women 3 months prior to, during and after pregnancy. The study population consisted of 345,703 singleton pregnancies during a period starting 1 April 2004 or later and ending before 1 January 2011. RESULTS: In 5,135 (1.5 %) of the pregnancies, the women were dispensed a benzodiazepine or z-hypnotic at least once. Of these, 68.5 % filled just one prescription for the duration of the pregnancy. Prevalence was lower in pregnancy than before and after pregnancy. The median total amount of benzodiazepines and/or z-hypnotics dispensed during pregnancy was 15 defined daily doses (DDDs), while the 25 % receiving the largest amounts got 40 DDDs or more. Five hundred eleven women, the 10 % that were prescribed the largest amounts during pregnancy, received a median amount of 220 DDDs. Women receiving these drugs were older, more often smokers, without a partner and suffering from chronic disease. Of the medicated pregnant women, 19.6 % and 19.3 % were also prescribed an opioid and antidepressant, respectively. CONCLUSIONS: The use of benzodiazepines and z-hypnotic drugs during pregnancy was not very prevalent in Norway. However, our findings imply that there is a substantial number of pregnancies where these drugs are dispensed often and/or in large quantities and where co-medication occurred.
Authors: I Lacroix; C Hurault; M F Sarramon; C Guitard; A Berrebi; M Grau; C Albouy-Cossard; R Bourrel; E Elefant; J L Montastruc; C Damase-Michel Journal: Eur J Clin Pharmacol Date: 2009-04-14 Impact factor: 2.953
Authors: A Lupattelli; O Spigset; M J Twigg; K Zagorodnikova; A C Mårdby; M E Moretti; M Drozd; A Panchaud; K Hämeen-Anttila; A Rieutord; R Gjergja Juraski; M Odalovic; D Kennedy; G Rudolf; H Juch; A Passier; I Björnsdóttir; H Nordeng Journal: BMJ Open Date: 2014-02-17 Impact factor: 2.692
Authors: Satu-Maarit Björkstedt; Hannu Kautiainen; Ulla Tuomi; Mika Gissler; Pirjo Pennanen; Johan G Eriksson; Merja K Laine Journal: Sci Rep Date: 2021-02-24 Impact factor: 4.379
Authors: Sarah Kittel-Schneider; Ethel Felice; Rachel Buhagiar; Mijke Lambregtse-van den Berg; Claire A Wilson; Visnja Banjac Baljak; Katarina Savic Vujovic; Branislava Medic; Ana Opankovic; Ana Fonseca; Angela Lupattelli Journal: Int J Environ Res Public Health Date: 2022-02-10 Impact factor: 3.390
Authors: Ludvig D Bjørndal; Fatima Tauqeer; Kristin S Heiervang; Hanne K Clausen; Kristine Heitmann; Angela Lupattelli Journal: BMJ Open Date: 2022-09-30 Impact factor: 3.006